BPA Fair-Value Pricing.
An independent check of whether a bulk-annuity quote is consistent with the risk-neutral fair value of the scheme's promise to members. The quote is reconciled onto the risk-neutral fair-value basis and tested for consistency. This is a fair-value consistency assessment: it does not predict the price an insurer will charge, and it makes no public claim about where a price sits in risk terms.
The promise to members has a single risk-neutral fair value — the benefit cashflows valued on a gilt basis, the audited primitive of the framework. A quote is reconciled onto that same basis and checked against it within a stated consistency tolerance. The output is a yes/no on fair-value consistency — expressible, where useful, as a Gilts + x figure — not a range, not a position in risk terms, and not a forecast of the price.
One reference, one clear consistency read.
A fair-value reference, constructed under the firm’s framework
The firm constructs a single fair-value reference for the scheme liabilities, on its own methodology, independent of the scheme’s funding basis and of the insurer’s quote basis. The reference is the benchmark against which the quote is read.
The quote translated into the same terms
The insurer’s quote is translated into terms consistent with the firm’s reference — net of the embedded risk-transfer premium, allowing for the residual obligations retained by the sponsor, and reconciled to the basis the trustee adviser has worked the scheme to.
A consistency read the sponsor can sign against
The output is a sponsor-side reading of whether the quote sits consistently with the firm’s fair-value reference, where it diverges, and what the divergence is in. Designed to support the sponsor’s board approval and post-transaction position.
Common questions about bulk annuity sponsor-side pricing.
Buyers come to the firm with several recurring questions about bulk annuity (BPA) transactions. The firm’s position on each is the same across buy-in, buy-out, and longevity-swap structures — the consistency read is the consistency read, regardless of the transaction shape.
The consistency read, not a price forecast.
Sponsor-side bulk annuity analysis reads an insurer’s quote against a single reference: the risk-neutral fair value of the scheme’s promise. The firm doesn’t forecast the market price; the firm tells the sponsor whether the price quoted is consistent with the value being transferred. Buy-in and buy-out transactions both go through the same consistency read.
What the price covers, broken out.
A bulk annuity price has identifiable components: the present value of pensioner benefit cashflows, the longevity risk transfer, the investment risk transfer, the insurer’s capital cost, and the margin. The firm’s analysis breaks these out so the sponsor can see where the quoted price sits against each component — particularly useful where a quote is high on one component and low on another, which a single headline price obscures.
No insurer ties. No broking pipeline. No transaction fee.
The bulk annuity market is concentrated; many advisers in the market have structural ties to specific insurers or operate broking pipelines that route business in particular directions. The firm has no insurer ties, no broking pipeline, and no transaction-completion fee — the engagement is paid on the same Statement of Work basis as the firm’s other Solutions. The sponsor’s reading of the quote is independent in fact, not just in claim.
Sponsors and their advisers evaluating a quote.
The engagement is structurally sponsor-side, intended to give the sponsor a quantitative reading on the quote that is independent of the trustee adviser bench.
Corporate sponsors at buy-in / buy-out
Finance directors, treasurers, and group finance teams at the sponsor entity, with a quote on the table from one or more insurers. Pre-quote, at-quote, or post-quote stage.
Sponsor-side transaction advisers
Corporate finance advisers, sponsor employee-benefits advisers, and transaction counsel acting for the sponsor on a buy-in or buy-out matter, who want a reference reading distinct from the trustee adviser’s.
Trustees seeking an independent reference
Trustee boards wanting a second-opinion reading on the quote separate from the scheme actuary or the broker, where the matter is sufficiently substantive to warrant it.
Bespoke per transaction; scoped at first conversation.
Pre-quote and at-quote reading
For sponsors evaluating quotes on the table or preparing to go to market. Engagement covers the fair-value reference construction, quote translation, divergence diagnostic, and board-ready summary. Scoped at first conversation; engagement letter agreed before work begins.
Post-transaction position
For sponsors needing a methodologically-defensible record of the position taken at quote acceptance — for board minutes, audit, or subsequent litigation. Scoped at first conversation; structured for the documentation context.
Statement of Work — how the fee is fixed
Engagements are scoped through a first conversation and then fixed in writing before any work begins. The firm’s Invitation Letter contains a Statement of Work fixing: the scope of the engagement, the timetable for delivery (key milestones and final-deliverable date), the price (with any stage payments scheduled against milestones), and the named individuals on both sides.
The scope-to-price conversion is based on the firm’s published charge-out rate: £350 per hour for engagements led by a Director or Senior Actuary (the only grades that lead engagements at Congruent). The Statement of Work converts scoped hours into a fixed fee — the buyer’s commercial commitment is to the fee in the Statement of Work, not to an open-ended hourly meter.
The firm tends to come in competitively on the fixed quote. Because Directors lead engagements directly — without the layered team structure typical of larger firms — scoped hours convert into a fixed fee that compares favourably against equivalent senior-led work elsewhere in the market.
Rate as at 1 January 2026, reviewed annually.
No insurer ties, no broking pipeline, no transaction fee.
The firm’s reading is structurally independent from both the insurer market and the trustee adviser bench. The firm does not act for insurers, does not have transaction-completion-dependent fee structures, and does not run a broking pipeline. The reading the sponsor receives is the firm’s methodological view of fair value, not an output calibrated to support a particular transaction outcome.
The methodological position behind the Solution.
The fair-value framework, the boundary of what the engagement does and doesn’t cover, and the substantive questions sponsors ought to ask before signing are set out in the firm’s Thinking piece on this Solution.
Discuss a transaction.
Brief context, transaction stage and timing — the firm responds within one working day with whether it can take the engagement and what it would need to scope it.